Cargando…
Anti-infective properties of proton pump inhibitors: perspectives
Infectious diseases are among the main causes of morbidity and mortality today. In facing this crisis, the development of new drug options and combat strategies is necessary. In this sense, drug repositioning or drug redirection has emerged for the faster identification of effective drugs. In this “...
Autores principales: | da Rosa, Taciéli Fagundes, Foletto, Vitória Segabinazzi, Serafin, Marissa Bolson, Bottega, Angelita, Hörner, Rosmari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413114/ https://www.ncbi.nlm.nih.gov/pubmed/34476634 http://dx.doi.org/10.1007/s10123-021-00203-y |
Ejemplares similares
-
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use
por: Foletto, Vitória Segabinazzi, et al.
Publicado: (2022) -
Drug repositioning is an alternative for the treatment of coronavirus COVID-19
por: Serafin, Marissa B., et al.
Publicado: (2020) -
Drug repositioning, a new alternative in infectious diseases
por: Serafin, Marissa Bolson, et al.
Publicado: (2018) -
When is proton pump inhibitor use appropriate?
por: Yadlapati, Rena, et al.
Publicado: (2017) -
Evidence-based support for the use of proton pump inhibitors in cancer therapy
por: Fais, Stefano
Publicado: (2015)